GTPBP1 Antikörper (N-Term)
Kurzübersicht für GTPBP1 Antikörper (N-Term) (ABIN952653)
Target
Alle GTPBP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 140-170, N-Term
-
Spezifität
- This antibody recognizes Human
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- conjugated synthetic peptide between 140-170 amino acids from the N-terminal region of human GTP-binding protein 1 / GBP1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- GTPBP1 (GTP Binding Protein 1 (GTPBP1))
-
Andere Bezeichnung
- GTP-Binding Protein 1 / GBP1
-
Hintergrund
- Guanylate binding protein expression is induced by interferon. Guanylate binding proteins are characterized by their ability to specifically bind guanine nucleotides (GMP, GDP, and GTP) and are distinguished from the GTP-binding proteins by the presence of 2 binding motifs rather than 3Synonyms: Guanine nucleotide-binding protein 1, HuGBP-1, Interferon-induced guanylate-binding protein 1
-
Molekulargewicht
- 67931 Da
-
Gen-ID
- 2633
-
NCBI Accession
- NP_002044
Target
-